April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
The Effect Of Intravitreous Administration Of Recombinant Tsg-6 Protein On The Retinal Lesion In Ccl2-/-/cx3cr1-/- Mice
Jingsheng Tuo; Xiaoguang Cao; Defen Shen; Yujuan Wang; Joo Youn Oh; Darwin J. Prockop,; Chi-Chao Chan
Author Affiliations & Notes
  • Jingsheng Tuo
    Laboratory of Immunology,
    National Eye Institute/NIH, Bethesda, Maryland
  • Xiaoguang Cao
    Immunopathology Section, NEI/LI, National Institutes of Health, Bethesda, Maryland
  • Defen Shen
    Laboratory of Immunology,
    National Eye Institute/NIH, Bethesda, Maryland
  • Yujuan Wang
    Laboratory of Immunology,
    National Eye Institute/NIH, Bethesda, Maryland
  • Joo Youn Oh
    Institute for Regenerative Medicine, Texas A&M Health Science Center, College of Medicine at Scott & White, Temple, Texas
  • Darwin J. Prockop,
    Institute for Regenerative Medicine, Texas A&M Health Science Center, College of Medicine at Scott & White, Temple, Texas
  • Chi-Chao Chan
    Immunopathol Section, Lab of Immunology,
    National Eye Institute/NIH, Bethesda, Maryland
  • Footnotes
    Commercial Relationships  Jingsheng Tuo, None; Xiaoguang Cao, None; Defen Shen, None; Yujuan Wang, None; Joo Youn Oh, None; Darwin J. Prockop,, None; Chi-Chao Chan, None
  • Footnotes
    Support  NEI Intramural Research Program
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1873. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      The Effect Of Intravitreous Administration Of Recombinant Tsg-6 Protein On The Retinal Lesion In Ccl2-/-/cx3cr1-/- Mice
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Jingsheng Tuo, Xiaoguang Cao, Defen Shen, Yujuan Wang, Joo Youn Oh, Darwin J. Prockop,, Chi-Chao Chan; The Effect Of Intravitreous Administration Of Recombinant Tsg-6 Protein On The Retinal Lesion In Ccl2-/-/cx3cr1-/- Mice. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1873.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : The inflammatory responses are detected in the retina of age-related macular degeneration (AMD) patients and Ccl2-/-/Cx3cr1-/- mice, a model that develops progressive AMD-like retinal lesions including focal deep retinal lesions, photoreceptor degeneration, abnormal retinal pigment epithelium, and A2E accumulation. Human mesenchymal stem cells or their anti-inflammatory protein, tumor necrosis factor-inducible gene 6 protein (TSG-6), have shown to improve myocardial infarction or chemically-injured cornea in mice. In this study, we evaluated the effect of intravitreous injection of recombinant TSG-6 on the retina lesions of Ccl2-/-/Cx3cr1-/- mice.

Methods: : Recombinant TSG-6 (400 ng) was intravitreously injected into the right eyes of 2-month-old Ccl2-/-/Cx3cr1-/- (n=26). The left eyes were injected with PBS as controls. Funduscopic pictures were taken before injection and sequentially once a month after injection. The mice were sacrificed 2 months after injection. Ocular histopathology was examined. Retinal A2E, a major component of lipofuscin, was measured by HPLC. The microarray of ocular mRNA of 94 immunological genes was performed. The genes showing differentiated expression in microarray were further compared for the injected right eyes and the contralateral (control) eyes by RT-PCR and Western blotting.

Results: : The continuous monitoring of the fundus showed a slower progression of retinal lesions in the treated right eyes as compared to the control left eyes. Among 21 pairs of eyes, 71.4% were improved, 18.9% stayed the same and 9.5% remained progressing in the lesion levels. Histology confirmed the clinical observation after 2 months. Even though there was no difference in the level of A2E between the treated eyes and the control eyes, microarray analysis of 94 immune genes showed that IL-17a was substantially decreased after the treatment. The results were consistent in duplicated array and confirmed by quantitative RT-PCR and Western Blotting.

Conclusions: : We concluded that intravitreous administration of recombinant TSG-6 might stabilize retinal lesions in Ccl2-/-/Cx3cr1-/- mice. The effect may act through modulation of ocular immunological gene expressions, especially IL-17a.

Keywords: age-related macular degeneration • inflammation • pathology: experimental 
© 2011, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept